• Biotoxtech CEO Kang Jong Koo bought 980 common shares on Oct. 22, 2026, at 2,029 won each.
• His holdings rose to 2,081,311 shares as of Oct. 26, with his stake unchanged at 13.04%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biotoxtech Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261026000221), on October 26, 2026, and is solely responsible for the information contained therein.